Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

4.1K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.1K
Telomeres and Telomerase02:41

Telomeres and Telomerase

25.8K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
25.8K
Telomeres and Telomerase02:41

Telomeres and Telomerase

6.4K
6.4K
Replication in Eukaryotes01:29

Replication in Eukaryotes

16.0K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
16.0K
Replication in Eukaryotes02:31

Replication in Eukaryotes

187.0K
Overview
187.0K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial.

Blood·2026
Same author

IGLV3-21<sup>R110</sup> and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL.

HemaSphere·2026
Same author

PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic Leukemia.

Blood advances·2026
Same author

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Nature communications·2026
Same author

Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network.

Lancet (London, England)·2026
Same author

CRISPR and compound screens in a novel ex vivo tissue model identify DDR1 and ETA as regulators of cancer cell invasion.

Cellular & molecular biology letters·2026
Same journal

Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report.

Frontiers in oncology·2026
Same journal

Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression.

Frontiers in oncology·2026
Same journal

Expert consensus from the Chinese medical association on pharmaceutical management of combined cardio-oncology physician-pharmacist clinics.

Frontiers in oncology·2026
Same journal

Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma.

Frontiers in oncology·2026
Same journal

The aMAP score improves discrimination of prognostic models in hepatocellular carcinoma after radiofrequency ablation.

Frontiers in oncology·2026
Same journal

Cuproptosis and prostate cancer: from molecular mechanisms and microenvironment remodeling to precision therapy.

Frontiers in oncology·2026
See all related articles

Related Experiment Video

Updated: Nov 19, 2025

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.6K

Telomere Dysfunction in Chronic Lymphocytic Leukemia.

Billy Michael Chelliah Jebaraj1, Stephan Stilgenbauer1,2

  • 1Department of Internal Medicine III, University of Ulm, Ulm, Germany.

Frontiers in Oncology
|February 1, 2021
PubMed
Summary
This summary is machine-generated.

Telomere dysfunction plays a dynamic role in chronic lymphocytic leukemia (CLL) progression. Shelterin complex and telomerase (TERT) alterations impact CLL cell survival and genomic complexity.

Keywords:
chronic lymphocytic leukemiaclonal evolutiongenomic complexityprognostic factortelomerase activationtelomere dysfunction

More Related Videos

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.3K
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.8K

Related Experiment Videos

Last Updated: Nov 19, 2025

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.6K
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.3K
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.8K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Telomeres protect chromosomal ends, ensuring genomic stability.
  • Altered telomere maintenance is linked to cancer development.
  • Short telomeres in chronic lymphocytic leukemia (CLL) indicate a poor prognosis.

Purpose of the Study:

  • To explore the dynamic role of telomere dysfunction in CLL pathogenesis.
  • To review the interplay between telomere maintenance and CLL progression.
  • To identify gaps in understanding TERT activation and shelterin deregulation in CLL.

Main Methods:

  • Literature review of published findings on telomeres in CLL.
  • Analysis of telomere length, shelterin complex expression, and POT1 mutations in CLL.
  • Examination of telomerase (TERT) expression and activity in relation to telomere length.

Main Results:

  • Telomere length is a prognostic factor in CLL.
  • Shelterin complex members show deregulated expression; POT1 mutations occur in CLL.
  • Short telomeres correlate with increased TERT expression and activity, supporting CLL cell survival.

Conclusions:

  • Telomere dysfunction is integral to CLL pathogenesis, progression, and clonal evolution.
  • TERT activation and shelterin deregulation are crucial for CLL cell survival and proliferation.
  • Mechanisms of shelterin deregulation and TERT activation in CLL require further investigation.